Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical scenarios of unusual FDG uptake in muscle.
Minamimoto R, Kato K, Naganawa S. Minamimoto R, et al. Jpn J Radiol. 2024 Oct 16. doi: 10.1007/s11604-024-01672-7. Online ahead of print. Jpn J Radiol. 2024. PMID: 39412643 Review.
Evaluation of X-ray protective goggles in mitigating eye lens radiation exposure during radiopharmaceutical handling and patient care in nuclear medicine.
Oikawa T, Saito K, Kurihara K, Horikawa D, Uruno K, Kajiwara H, Ohashi S, Hotta M, Yagi N, Kitamura H, Hasegawa S, Minamimoto R. Oikawa T, et al. Among authors: minamimoto r. Glob Health Med. 2024 Aug 31;6(4):244-250. doi: 10.35772/ghm.2024.01023. Glob Health Med. 2024. PMID: 39219587 Free PMC article.
Prevalence and associated factors of low vigor in patients living with HIV and hemophilia in Japan: A cross-sectional observational study.
Komatsu K, Kimura S, Kiryu Y, Watanabe A, Kinai E, Oka S, Kimura S, Fujitani J, Ogata M, Minamimoto R, Hotta M, Yokoyama K, Noguchi T, Imai K. Komatsu K, et al. Among authors: minamimoto r. Glob Health Med. 2024 Jun 30;6(3):174-182. doi: 10.35772/ghm.2023.01108. Glob Health Med. 2024. PMID: 38947408 Free PMC article.
Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer.
Kawai T, Taguchi S, Nozaki K, Kimura N, Oshina T, Iwaki T, Matsui H, Niimi A, Kamei J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Kaneko T, Sawayanagi S, Nakayama H, Minamimoto R, Yamashita H, Miyazaki H, Fujimura T, Nakagawa T, Kume H. Kawai T, et al. Among authors: minamimoto r. Prostate Int. 2023 Dec;11(4):239-246. doi: 10.1016/j.prnil.2023.10.002. Epub 2023 Oct 21. Prostate Int. 2023. PMID: 38196558 Free PMC article.
160 results